Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

BIAS: Center
RELIABILITY: Mixed
CNBC
15:05Z

Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the booming GLP-1 space.

Continue reading at the original source

Read Full Article at CNBC →